Assessment of the ‘Managing Advanced Cancer Pain Together’ (MACPT) tool to facilitate communication on total cancer pain between advanced cancer patients and their healthcare professionals (20160376)

Study identification

• EU PAS number:
  EUPAS25858
• Study ID:
  39584
• Official title and acronym:
  Assessment of the ‘Managing Advanced Cancer Pain Together’ (MACPT) tool to facilitate communication on total cancer pain between advanced cancer patients and their healthcare professionals (20160376)
• DARWIN EU® study:
  No
• Study countries:
  France

  Germany

  United Kingdom
• Study description:
  The research focus is the assessment of a paper based conversation tool, the ‘Managing Advanced Cancer Pain Together’ (MACPT) conversation tool, developed to support a comprehensive pain dialogue between the patient and healthcare practitioner (HCP) during their routine face-to-face consultation.
• Study status:
  Finalised

Research institutions and networks

Institutions

Amgen

United States

Multiple centres: 4 centres are involved in the study

Study timelines

Date when funding contract was signed

Actual:29/05/2017

Study start date

Planned:31/01/2019

Actual:04/01/2019

Data analysis start date

Planned:01/06/2021

Actual:18/12/2020

Date of final study report

Planned:02/03/2021

Actual:19/02/2021

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Amgen

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable